FRANKFURT, Jan 22 (Reuters) - AstraZeneca has
informed the European Commission that it will initially not be
able to deliver the agreed volumes of its COVID-19 vaccine when
it obtains regulatory approval for the bloc, which is expected
by end-January, German newspaper Bild reported on Friday, citing
company sources.
An AstraZeneca spokesman did not have an immediate comment
when contacted by Reuters.
(Reporting by Ludwig Burger; editing by Thomas Seythal)